Rose hip is a plant-derived supplement used for joint symptom relief. Benefits remain inconsistent and preparation-dependent; no longer human life has been demonstrated. Possible symptom improvement may support activity, but digestive discomfort, allergy, medication-absorption changes, misleading laboratory results, and uncertain long-term safety matter. A clearly identified product and a defined, observable outcome are more meaningful than broad antioxidant claims. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Resting blood pressure | No established target; track change from baseline | Expected-effect and symptomatic-low-pressure check |
| Low-density lipoprotein cholesterol | No established target; track change from baseline | Expected-effect marker |
Cadence: Baseline; tolerance weekly; pressure at 2–6 weeks; cholesterol at 6–12 weeks; joint symptoms and activity at baseline, 6 and 12 weeks. Pragmatic intervals, not a validated safety schedule.